Simultaneous quantification of teneligliptin hydrobromide and metformin hydrochloride: An improved HPTLC method with implementation of Plackett-Burman design
Mehul Patel, Divya Patel, Umang Shah, Hetaben Kachhiya
Abstract
Simple, rapid, sensitive, robust, and validated high-performance thin-layer chromatography was developed for the simultaneous estimation of anti-diabetic drugs Teneligliptin hydrobromide (TH) and Metformin hydrochloride (MH) in bulk and pharmaceutical formulation. HPTLC system equipped Camag Linomat V, TLC Scanner IV, Twin Trough chamber, Dual-wavelength UV Cabinet, and win CATS software V1.4.7 were used during the study. Separation of analytes was achieved using a pre-coated silica gel G60 F254 aluminum sheets 1010 cm 2 , with the thickness of 0.2 mm as stationary phase and a mobile phase comprising of Methanol: Ammonium sulfate (0.5 %w/v): Triethylamine (9: 2.7: 0.5 v/v/v). The detection wavelength was set at 237 nm. The Rf value of the TH and MH was 0.63 and 0.19, respectively. The method was validated using a dynamic linear range of 4-28 ng/band and 100-700 ng/band for TH and MH, respectively. The developed method was validated as per the ICHQ2 (R1) guideline. The statistical analysis proved that the process is accurate with 98.80-99.38 % w/v and 99.66-99.96 % w/v for TH and MH, respectively, and precise with less than 2 % RSD. The Plackett-Burman design was applied to check the robustness of the developed method. Finally, the method is termed as linear, precise, accurate, and robust. It can be implemented successfully for the routine analysis of pharmaceutical dosage forms comprising TH and MH and is appropriate for regulatory submission under regulatory flexibility.